Showing results (581-590 of 9,788) with videos related to
Sort By:
Pageof 979
The Journal of Clinical Investigation|July 16, 2009
Treating MS: getting to know the two birds in the bushTerri M Laufer, Gregory F WuPediatric Research|November 18, 2009
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerationsMark A Travassos, Miriam K LauferAmerican Journal of Infection Control|April 1, 1994
Application of cost-effectiveness methodology to the consideration of needlestick-prevention technologyF N Laufer, L A ChiarelloExperientia|April 15, 1978
Effect of papain on experimental amyloidosisJ Kopolovicz, M Fields, A LauferComparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1991
Methyl farnesoate in the prawn Macrobrachium rosenbergii: synthesis by the mandibular organ in vitro, and titers in the hemolymphA Sagi, E Homola, H LauferEuropean Journal of Medicinal Chemistry|August 4, 2020
Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationshipsOliver Laufkötter, Stefan Laufer, Jürgen BajorathOsteoarthritis and Cartilage|December 5, 2002
An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugsS Laufer, C Greim, T BertscheInflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 15, 2002
The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2S Tries, W Neupert, S LauferActa Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-(4-Fluoro-phen-yl)-3-(4-pyrid-yl)pyrido[2,3-b]pyrazinePierre Koch, Dieter Schollmeyer, Stefan LauferActa Crystallographica. Section E, Structure Reports Online|May 18, 2011
3-(4-Fluoro-phen-yl)-2-(4-pyrid-yl)pyrido[2,3-b]pyrazinePierre Koch, Dieter Schollmeyer, Stefan LauferPageof 979